Modification of papillomavirus E2 proteins by the small ubiquitin-like modifier family members (SUMOs)

Virology

Volumn 378, Issue 2, 2008, Pages 329-338

  Wu, Yu Chieh ^a   Roark, Ashley A ^a   Bian, Xue Lin ^a   Wilson, Van G ^a  

^a TEXAS A M COLLEGE OF MEDICINE   (United States)

Author keywords

Keratinocytes; Sumoylation; Transcription

Indexed keywords

PAPILLOMAVIRUS E2 PROTEIN; PROTEIN SUMO 2; PROTEIN SUMO 3; SUMO 1 PROTEIN; SUMO PROTEIN; VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; ESCHERICHIA COLI; GENE REPLICATION; GENETIC TRANSCRIPTION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; PAPILLOMA VIRUS; PRIORITY JOURNAL;

AMINO ACID SUBSTITUTION; ANIMALS; CATTLE; CELL LINE; DNA, VIRAL; DNA-BINDING PROTEINS; GENE EXPRESSION; HUMANS; MUTAGENESIS, SITE-DIRECTED; MUTATION, MISSENSE; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PROTEIN BINDING; PROTEIN PROCESSING, POST-TRANSLATIONAL; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; SUMO-1 PROTEIN; TRANSCRIPTION, GENETIC; UBIQUITIN-CONJUGATING ENZYMES; UBIQUITINS; VIRAL PROTEINS;

BOVINAE; HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRIDAE;

EID: 49049092114     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2008.06.008     Document Type: Article

References (77)

1. Bastien N., and McBride A.A. Interaction of the papillomavirus E2 protein with mitotic chromosomes. Virology 270 1 (2000) 124-134
2. Baxter M.K., McPhillips M.G., Ozato K., and McBride A.A. The mitotic chromosome binding activity of the papillomavirus E2 protein correlates with interaction with the cellular chromosomal protein, Brd4. J. Virol. 79 8 (2005) 4806-4818
3. Bellanger S., Demeret C., Goyat S., and Thierry F. Stability of the human papillomavirus type 18 E2 protein is regulated by a proteasome degradation pathway through its amino-terminal transactivation domain. J. Virol. 75 16 (2001) 7244-7251
4. Benson J.D., Lawande R., and Howley P.M. Conserved interaction of the papillomavirus E2 transcriptional activator proteins with human and yeast TFIIB proteins. J. Virol. 71 10 (1997) 8041-8047
5. Bernard B.A., Bailly C., Lenoir M.C., Darmon M., Thierry F., and Yaniv M. The human papillomavirus type 18 (HPV18) E2 gene product is a repressor of the HPV18 regulatory region in human keratinocytes. J. Virol. 63 (1989) 4317-4324
6. Breiding D.E., Sverdrup F., Grossel M.J., Moscufo N., Boonchai W., and Androphy E.J. Functional interaction of a novel cellular protein with the papillomavirus E2 transactivation domain. Mol. Cell. Biol. 17 12 (1997) 7208-7219
7. Chang L.K., Lee Y.H., Cheng T.S., Hong Y.R., Lu P.J., Wang J.J., Wang W.H., Kuo C.W., Li S.S.L., and Liu S.T. Post-translational modification of Rta of Epstein-Barr virus by SUMO-1. J. Biol. Chem. 279 37 (2004) 38803-38812
8. Chiang C.M., Dong G., Broker T.R., and Chow L.T. Control of human papillomavirus type 11 origin of replication by the E2 family of transcription regulatory proteins. J. Virol. 66 9 (1992) 5224-5231
9. Chung T.L., Hsiao H.H., Yeh Y.Y., Shia H.L., Chen Y.L., Liang P.H., Wang A.H.J., Khoo K.H., and Li S.S.L. In vitro modification of human centromere protein CENP-C fragments by small ubiquitin-like modifier (SUMO) protein - Definitive identification of the modification sites by tandem mass spectrometry analysis of the isopeptides. J. Biol. Chem. 279 38 (2004) 39653-39662
10. Demeret C., Desaintes C., Yaniv M., and Thierry F. Different mechanisms contribute to the E2-mediated transcriptional repression of human papillomavirus type 18 viral oncogenes. J. Viro. 71 12 (1997) 9343-9349
11. Demeret C., Lemoal M., Yaniv M., and Thierry F. Control of HPV 18 DNA replication by cellular and viral transcription factors. Nucleic. Acids. Res. 23 23 (1995) 4777-4784
12. Desterro J.M.P., Rodriguez M.S., Kemp G.D., and Hay R.T. Identification of the enzyme required for activation of the small ubiquitin-like protein SUMO-1. J. Biol. Chem. 274 15 (1999) 10618-10624
13. Deyrieux A.F., Rosas-Acosta G., Ozbun M.A., and Wilson V.G. Sumoylation dynamics during keratinocyte differentiation. J. Cell. Sci. 120 Pt 1 (2007) 125-136
14. Dohmen R.J. SUMO protein modification. Biochim. Biophys. Acta. 1695 1-3 (2004) 113-131
15. Dowhanick J.J., McBride A.A., and Howley P.M. Suppression of cellular proliferation by the papillomavirus E2 protein. J. Virol. 69 12 (1995) 7791-7799
16. Ferguson M.K., and Botchan M.R. Genetic analysis of the activation domain of bovine papillomavirus protein E2 - its role in transcription and replication. J. Virol. 70 7 (1996) 4193-4199
17. Francis D.A., Schmid S.I., and Howley P.M. Repression of the integrated papillomavirus E6/E7 promoter is required for growth suppression of cervical cancer cells. J. Virol. 74 6 (2000) 2679-2686
18. Gill G. Something about SUMO inhibits transcription. Curr. Opin. Genet. Develop. 15 5 (2005) 536-541
19. Girdwood D., Bumpass D., Vaughan O.A., Thain A., Anderson L.A., Snowden A.W., Garcia-Wilson E., Perkins N.D., and Hay R.T. p300 transcriptional repression is mediated by SUMO modification. Mol. Cell. 11 4 (2003) 1043-1054
20. Gonzalez A., Bazaldua-Hernandez C., West M., Woytek K., and Wilson V.G. Identification of a short, hydrophilic amino acid sequence critical for origin recognition by the bovine papillomavirus E1 protein. J. Virol. 74 (2000) 245-253
21. Goodson M.L., Hong Y., Rogers R., Matunis M.J., Park-Sarge O.K., and Sarge K.D. SUMO-1 modification regulates the DNA binding activity of heat shock transcription factor 2, a promyelocytic leukemia nuclear body associated transcription factor. J. Biol. Chem. 276 21 (2001) 18513-18518
22. Hadaschik D., Hinterkeuser K., Oldak M., Pfister H.J., and Smola-Hess S. The papillomavirus E2 protein binds to and synergizes with C/EBP factors involved in keratinocyte differentiation. J. Virol. 77 9 (2003) 5253-5265
23. Ham J., Steger G., and Yaniv M. Cooperativity in vivo between the E2 transactivator and the TATA box binding protein depends on core promoter structure. EMBO J. 13 1 (1994) 147-157
24. Hay R.T. SUMO: A history of modification. Mol. Cell. 18 1 (2005) 1-12
25. Hegde R.S., and Androphy E.J. Crystal structure of the E2 DNA-binding domain from human papillomavirus type 16: Implications for its DNA binding-site selection mechanism. J. Mol. Biol. 284 5 (1998) 1479-1489
26. Hirochika H., Hirochika R., Broker T.R., and Chow L.T. Functional mapping of the human papillomavirus type 11 transcriptional enhancer and its interaction with the trans-acting E2 proteins. Genes Dev. 2 1 (1988) 54-67
27. Hong Y.L., Rogers R., Matunis M.J., Mayhew C.N., Goodson M., Park-Sarge O.K., and Sarge K.D. Regulation of heat shock transcription factor 1 by stress-induced SUMO-1 modification. J. Biol. Chem. 276 43 (2001) 40263-40267
28. Hwang E.S., Riese D.J., Settleman J., Nilson L.A., Honig J., Flynn S., and DiMaio D. Inhibition of cervical carcinoma cell line proliferation by the introduction of a bovine papillomavirus regulatory gene. J. Virol. 67 7 (1993) 3720-3729
29. Ilves I., Maemets K., Silla T., Janikson K., and Ustav M. Brd4 is involved in multiple processes of the bovine papillomavirus type 1 life cycle. J. Virol. 80 7 (2006) 3660-3665
30. Izumiya Y., Ellison T.J., Yeh E.T.H., Jung J.U., Luciw P.A., and Kung H.J. Kaposi's sarcoma-associated herpesvirus K-bZIP represses gene transcription via SUMO modification. J. Virol. 79 15 (2005) 9912
31. Klucevsek K., Wertz M., Lucchi J., Leszczynski A., and Moroianu J. Characterization of the nuclear localization signal of high risk HPV16 E2 protein. Virology 360 1 (2007) 191-198
32. Kovelman R., Bilter G.K., Glezer E., Tsou A.Y., and Barbosa M.S. Enhanced transcriptional activation by E2 proteins from the oncogenic human papillomaviruses. J. Virol. 70 11 (1996) 7549-7560
33. Lee D., Hwang S.G., Kim J., and Choe J. Functional interaction between p/CAF and human papillomavirus E2 protein. J. Biol. Chem. 277 8 (2002) 6483-6489
34. Lee D., Lee B., Kim J., Kim D.W., and Choe J. cAMP response element-binding protein-binding protein binds to human papillomavirus E2 protein and activates E2-dependent transcription. J. Biol. Chem. 275 10 (2000) 7045-7051
35. Lee K.Y., Broker T.R., and Chow L.T. Transcription factor YY1 represses cell-free replication from human papillomavirus origins. J. Virol. 72 6 (1998) 4911-4917
36. Leng X., Ludes-Meyers J.H., and Wilson V.G. Isolation of an amino-terminal region of bovine papillomavirus type 1 E1 protein that retains origin binding and E2 interaction capacity. J. Virol. 71 1 (1997) 848-852
37. Lewis H., Webster K., Sanchez-Perez A.M., and Gaston K. Cellular transcription factors regulate human papillomavirus type 16 gene expression by binding to a subset of the DNA sequences recognized by the viral E2 protein. J. Gen. Virol. 80 Part 8 (1999) 2087-2096
38. Li R., Knight J.D., Jackson S.P., Tjian R., and Botchan M.R. Direct interaction between Sp1 and the BPV enhancer E2 protein mediates synergistic activation of transcription. Cell 65 3 (1991) 493-505
39. Li S.J., and Hochstrasser M. A new protease required for cell-cycle progression in yeast. Nature 398 6724 (1999) 246-251
40. Longworth M.S., and Laimins L.A. Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiol. Mol. Biol. Rev. 68 2 (2004) 362-373
41. Matunis M.J., Coutavas E., and Blobel G. A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex. J. Cell Biol. 135 6 (1996) 1457-1470
42. McPhillips M.G., Oliveira J.G., Spindler J.E., Mitra R., and McBride A.A. Brd4 is required for E2-mediated transcriptional activation but not genome partitioning of all papillomaviruses. J. Virol. 80 19 (2006) 9530-9543
43. Mukhopadhyay D., and Dasso M. Modification in reverse: the SUMO proteases. Trends Biochem. Sci. 32 6 (2007) 286-295
44. Muller A., Ritzkowsky A., and Steger G. Cooperative activation of human papillomavirus type 8 gene expression by the E2 protein and the cellular coactivator p300. J. Virol. 76 21 (2002) 11042-11053
45. Peng Y.C., Breiding D.E., Sverdrup F., Richard J., and Androphy E.J. AMF-1/Gps2 binds p300 and enhances its interaction with papillomavirus E2 proteins. J. Virol. 74 13 (2000) 5872-5879
46. Penrose K.J., and McBride A.A. Proteasome-mediated degradation of the papillomavirus E2-TA protein is regulated by phosphorylation and can modulate viral genome copy number. J. Virol. 74 13 (2000) 6031-6038
47. Phelps W.C., and Howley P.M. Transcriptional trans-activation by the human papillomavirus type 16 E2 gene product. J. Virol. 61 5 (1987) 1630-1638
48. Rangasamy D., and Wilson V.G. Bovine papillomavirus E1 protein is sumoylated by the host cell Ubc9 protein. J. Biol. Chem. 275 39 (2000) 30487-30495
49. Rank N.M., and Lambert P.F. Bovine papillomavirus type 1 E2 transcriptional regulators directly bind two cellular transcription factors, TFIID and TFIIB. J. Virol. 69 10 (1995) 6323-6334
50. Rodriguez M.S., Desterro J.M.P., Lain S., Midgley C.A., Lane D.P., and Hay R.T. SUMO-1 modification activates the transcriptional response of p53. EMBO. J. 18 (1999) 6455-6461
51. Rosas-Acosta G., Langereis M.A., Deyrieux A., and Wilson V.G. Proteins of the PIAS family enhance the sumoylation of the papillomavirus E1 protein. Virology 331 1 (2005) 190-203
52. Rosas-Acosta G., Russell W.K., Deyrieux A., Russell D.H., and Wilson V.G. A universal strategy for proteomics studies of SUMO and other ubiquitin-like modifiers. Mol. Cell. Proteomics 4 1 (2005) 56-72
53. Ross S., Best J.L., Zon L.I., and Gill G. SUMO-1 modification represses Sp3 transcriptional activation and modulates its subnuclear localization. Mol. Cell 10 4 (2002) 831-842
54. Sakai H., Yasugi T., Benson J.D., Dowhanick J.J., and Howley P.M. Targeted mutagenesis of the human papillomavirus type 16 E2 transactivation domain reveals separable transcriptional activation and DNA replication functions. J. Virol. 70 (1996) 1602-1611
55. Schmidt D., and Muller S. PIAS/SUMO: new partners in transcriptional regulation. Cell. Mol. Life Sci. 60 12 (2003) 2561-2574
56. Schweiger M.R., Ottinger M., You J., and Howley P.M. Brd4-independent transcriptional repression function of the papillomavirus E2 proteins. J. Virol. 81 18 (2007) 9612-9622
57. Schweiger M.R., You J.X., and Howley P.M. Bromodomain protein 4 mediates the papillomavirus E2 transcriptional activation function. J. Virol. 80 9 (2006) 4276-4285
58. Senechal H., Poirier G.G., Coulombe B., Laimins L.A., and Archambault J. Amino acid substitutions that specifically impair the transcriptional activity of papillomavirus E2 affect binding to the long isoform of Brd4. Virology 358 1 (2007) 10-17
59. Spalholz B.A., Yang Y.C., and Howley P.M. Transactivation of a bovine papilloma virus transcriptional regulatory element by the E2 gene product. Cell 42 1 (1985) 183-191
60. Steger G., and Corbach S. Dose-dependent regulation of the early promoter of human papillomavirus type 18 by the viral E2 protein. J. Virol. 71 1 (1997) 50-58
61. Steger G., Ham J., Lefebvre O., and Yaniv M. The bovine papillomavirus 1 E2 protein contains two activation domains: one that interacts with TBP and another that functions after TBP binding. EMBO. J. 14 2 (1995) 329-340
62. Steger G., Schnabel C., and Schmidt H.M. The hinge region of the human papillomavirus type 8 E2 protein activates the human p21(WAF1/CIP1) promoter via interaction with Sp1. J. Gen. Virol. 83 Part 3 (2002) 503-510
63. Stenlund A., and Botchan M.R. The E2 trans-activator can act as a repressor by interfering with a cellular transcription factor. Genes Dev. 4 3 (1990) 476
64. Stubenrauch F., Colbert A.M.E., and Laimins L.A. Transactivation by the E2 protein of oncogenic human papillomavirus type 31 is not essential for early and late viral functions. J. Virol. 72 10 (1998) 8115-8123
65. Tan S.H., Gloss B., and Bernard H.U. During negative regulation of the human papillomavirus-16 E6 promoter, the viral E2 protein can displace Sp1 from a proximal promoter element. Nucleic Acids Res. 20 2 (1992) 251-256
66. Tan S.-H., Leong L.E.-C., Walker P.A., and Bernard H.-U. The human papillomavirus type 16 E2 transcription factor binds with low cooperativity to two flanking sites and represses the E6 promoter through displacement of Sp1 and TFIID. J. Virol. 68 10 (1994) 6411-6420
67. Thierry F., and Yaniv M. The BPV1-E2 trans-acting protein can be either an activator or a repressor of the HPV18 regulatory region. EMBO. J. 6 11 (1987) 3391-3397
68. Uchimura Y., Nakamura M., Sugasawa K., Nakao M., and Saitoh H. Overproduction of eukaryotic SUMO-1- and SUMO-2-conjugated proteins in Escherichia coli. Analytical Biochem. 331 1 (2004) 204-206
69. Uchimura Y., Nakao M., and Saitoh H. Generation of SUMO-1 modified proteins in E. coli: towards understanding the biochemistry/structural biology of the SUMO-1 pathway. FEBS Lett. 564 1-2 (2004) 85-90
70. Verger A., Perdomo J., and Crossley M. Modification with SUMO - A role in transcriptional regulation. EMBO Rep. 4 2 (2003) 137-142
71. Voitenleitner C., and Botchan M. E1 protein of bovine papillomavirus type 1 interferes with E2 protein-mediated tethering of the viral DNA to mitotic chromosomes. J. Virol. 76 7 (2002) 3440-3451
72. Wei F., Scholer H.R., and Atchison M.L. Sumoylation of Oct4 enhances its stability, DNA binding, and transactivation. J. Biol. Chem. 282 29 (2007) 21551-21560
73. Wilson V.G., and Rangasamy D. Intracellular targeting of proteins by sumoylation. Exp. Cell Res. 271 1 (2001) 57-65
74. Wu S.Y., Lee A.Y., Hou S.Y., Kemper J.K., Erdjument-Bromage H., Tempst P., and Chiang C.M. Brd4 links chromatin targeting to HPV transcriptional silencing. Genes Dev. 20 17 (2006) 2383-2396
75. Yang S.H., and Sharrocks A.D. SUMO promotes HDAC-mediated transcriptional repression. Mol. Cell 13 4 (2004) 611-617
76. Yao J.M., Breiding D.E., and Androphy E.J. Functional interaction of the bovine papillomavirus E2 transactivation domain with TFIIB. J. Virol. 72 (1998) 1013-1019
77. You J., Croyle J.L., Nishimura A., Ozato K., and Howley P.M. Interaction of the bovine papillomavirus E2 protein with Brd4 tethers the viral DNA to host mitotic chromosomes. Cell 117 3 (2004) 349-360